等待开盘 10-13 09:30:00 美东时间
-1.220
-2.29%
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从62.5美元升至65美元;摩根士丹利:维持Hut 8"超配"评级,目标价从273美元升至275美元
今天 12:30
Stifel analyst Annabel Samimy maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $70 to $84.
10-12 19:19
今日重点评级关注:Truist Securities:维持Inventiva"买入"评级,目标价从13美元升至18美元;富瑞:维持Sagimet Biosciences"买入"评级,目标价从25美元升至26美元
10-05 16:26
Guggenheim analyst Seamus Fernandez maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $88 to $150.
10-02 21:05
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Monday. Shares of Kodiak Sciences Inc (NASDAQ:KOD) rose sharply after the company released data from the Phase 3 DAYBREAK trial for patients suffering from wet age-related macular degeneration (wAMD). The study showed that b...
09-29 02:25
MBX Biosciences appoints Jeff Held as Chief Legal Officer. With over 30 years of experience in biotech and healthcare, Held will support the company's growth and strategic initiatives. MBX granted him an inducement equity award, including stock options and RSUs, as part of his appointment. The company focuses on developing precision peptide therapies for endocrine and metabolic disorders.
09-08 12:00
MBX Biosciences, Inc. ( ($MBX) ) just unveiled an update. On August 27, 2026, M...
08-27 20:58
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40
JP Morgan analyst Jessica Fye reinstates MBX Biosciences (NASDAQ:MBX) with a Overweight and announces $88 price target.
08-22 03:01
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45